GlassScriptPhysician profile
Jyoti Chaudhary
NPI 1912214453
$5,099.41
in general payments reported to CMS, 2019-2025
33 companies · $1,346 in 2025
The $1,346 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $177 · 2021: $651 · 2022: $1,097 · 2023: $696 · 2024: $510 · 2025: $1,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,551.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,078.32 | 2019-2025 | Tavneos, Krystexxa, Evenity |
| Glaxosmithkline, LLC. | $683.20 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $574.06 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $461.36 | 2019-2023 | |
| Pfizer INC. | $306.81 | 2020-2025 | |
| Ucb, INC. | $284.39 | 2019-2025 | Cimzia |
| Novartis Pharmaceuticals Corporation | $267.34 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $164.12 | 2019-2024 | Xifaxan, Trulance |
| Astrazeneca Pharmaceuticals LP | $135.10 | 2021-2025 | Farxiga, Breztri |
| Horizon Therapeutics Plc | $125.02 | 2022 | |
| Janssen Scientific Affairs, LLC | $124.99 | 2022 | |
| Abbott Laboratories | $117.67 | 2021-2024 | Jeti Peripheral Catheter, Freestyle Libre 3 |
| Mylan Specialty L.P. | $102.86 | 2021-2023 | Yupelri |
| Abbvie INC. | $84.27 | 2019-2022 | |
| Sequel Med Tech, LLC | $65.76 | 2025 | Twiist |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $63.47 | 2022-2025 | Inceptiv, Minimed 780g |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.77 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $40.75 | 2022 | |
| Phathom Pharmaceuticals, INC. | $39.81 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $39.56 | 2022-2023 | Mounjaro |
| Exact Sciences Corporation | $37.13 | 2023 | Cologuard Collection Kit |
| Nestle Healthcare Nutrition INC. | $35.17 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $26.19 | 2021 | |
| Daiichi Sankyo INC. | $24.65 | 2020 | |
| Astellas Pharma US INC | $24.37 | 2019-2020 | |
| Corcept Therapeutics | $22.26 | 2021 | |
| Seqirus USA INC | $20.97 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.72 | 2022 | |
| Viatris Specialty LLC | $17.98 | 2025 | Yupelri |
| Dexcom, INC. | $16.53 | 2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $15.28 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.87 | 2019 | |
| Eisai INC. | $11.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jyoti Chaudhary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.